Indication

Psoriatic arthritis

Psoriatic arthritis is a chronic, immune-mediated inflammatory musculoskeletal disorder that develops in a subset of patients with psoriasis, typically presenting between the ages of 30 and 50. Read more about Psoriatic arthritis

547 drugs 201 manufacturers

Drugs that treat it

Common Psoriatic arthritis therapies.

Showing 163–171 of 547 drugs

Sort

TRIAMCINOLONE ACETONIDE

GLUCOCORTICOSTEROIDS·TRICHINOSIS·+53

AMNEAL BIOSCIEN

DEXAMETHASONE SODIUM PHOSPHATE

GLUCOCORTICOSTEROIDS·DISSEMINATED TUBERCULOSIS·+60

FRESENIUS KABI

HYDROCORTISONE

TRICHINOSIS·+51

IMPAX GENERICS

ENBREL MINI (etanercept)

ANTIPSORIATICS·PSORIATIC ARTHRITIS·+4

AMGEN

MAS CARE-PAK (dexamethasone sodium phosphate/PF)

GLUCOCORTICOSTEROIDS·DISSEMINATED TUBERCULOSIS·+60

MAS MANAGEMENT

DECADRON (dexamethasone)

DISSEMINATED TUBERCULOSIS·+61

PRAGMA/FERA PHA

DECADRON (dexamethasone)

DISSEMINATED TUBERCULOSIS·+61

PRAGMA PHARMACE

DEXAMETHASONE SODIUM PHOSPHATE (dexamethasone sodium phosphate/PF)

DISSEMINATED TUBERCULOSIS·+60

SOMERSET PHARM

TAPERDEX (dexamethasone)

GLUCOCORTICOSTEROIDS·DISSEMINATED TUBERCULOSIS·+61

XSPIRE PHARMA

Filter & compare in the drug finder →Opens the drug finder with Psoriatic arthritis preselected.

News & literature

Coming soon

Related codes

Coming soon

About Psoriatic arthritis.

Psoriatic arthritis is a chronic, immune-mediated inflammatory musculoskeletal disorder that develops in a subset of patients with psoriasis, typically presenting between the ages of 30 and 50.

It is classified as a seronegative spondyloarthritis characterized by synovitis, enthesitis, and dactylitis, frequently accompanied by psoriatic cutaneous plaques and dystrophic nail changes.

Clinical manifestations can involve asymmetric or symmetric peripheral oligo- or polyarthritis, distal interphalangeal joint predilection, and axial skeleton involvement.

Driven by dysregulated immune pathways including tumor necrosis factor and the interleukin-23/interleukin-17 axis, unchecked inflammation can lead to progressive articular cartilage destruction and pathologic bone remodeling.

medlineplus.gov
Psoriatic arthritis is a chronic, immune-mediated inflammatory musculoskeletal disorder that develops in a subset of patients with psoriasis, typically presenting between the ages of 30 and 50 It is classified as a seronegative spondyloarthritis characterized by synovitis, enthesitis, and dactylitis, frequently accompanied by psoriatic cutaneous plaques and dystrophic nail changes Clinical manifestations can involve asymmetric or symmetric peripheral oligo- or polyarthritis, distal interphalange...
nih.gov
Psoriatic arthritis is a chronic, immune-mediated inflammatory musculoskeletal disorder that develops in a subset of patients with psoriasis, typically presenting between the ages of 30 and 50 It is classified as a seronegative spondyloarthritis characterized by synovitis, enthesitis, and dactylitis, frequently accompanied by psoriatic cutaneous plaques and dystrophic nail changes Driven by dysregulated immune pathways including tumor necrosis factor and the interleukin-23/interleukin-17 axis, u...
nih.gov
Psoriatic arthritis is a chronic, immune-mediated inflammatory musculoskeletal disorder that develops in a subset of patients with psoriasis, typically presenting between the ages of 30 and 50
nih.gov
It is classified as a seronegative spondyloarthritis characterized by synovitis, enthesitis, and dactylitis, frequently accompanied by psoriatic cutaneous plaques and dystrophic nail changes
nih.gov
It is classified as a seronegative spondyloarthritis characterized by synovitis, enthesitis, and dactylitis, frequently accompanied by psoriatic cutaneous plaques and dystrophic nail changes Clinical manifestations can involve asymmetric or symmetric peripheral oligo- or polyarthritis, distal interphalangeal joint predilection, and axial skeleton involvement
nih.gov
It is classified as a seronegative spondyloarthritis characterized by synovitis, enthesitis, and dactylitis, frequently accompanied by psoriatic cutaneous plaques and dystrophic nail changes
nih.gov
Clinical manifestations can involve asymmetric or symmetric peripheral oligo- or polyarthritis, distal interphalangeal joint predilection, and axial skeleton involvement
nih.gov
Clinical manifestations can involve asymmetric or symmetric peripheral oligo- or polyarthritis, distal interphalangeal joint predilection, and axial skeleton involvement

Personalize your experience

Follow Psoriatic arthritis and get updates as they land.

Create a free account

Already a member? Sign in

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it